Reusable Insulin Delivery Device Gains 6% Duty Concession; Entitlement to Cenvat Credit on Inputs and Services Upheld.

The Tribunal concluded that the Reusable Insulin Delivery Device, classified under Chapter sub-heading 9018 3100 as 'Syringes without needles', is eligible for a concessional duty rate of 6% under Serial No. 310 of Notification No. 12/2012-CE. Consequently, the appellant's entitlement to Cenvat credit on inputs and input services was affirmed, overturning the Department's demands. The impugned orders-in-appeal were set aside, and the appeals were allowed.

---

---

Issues:
The issues involved in the judgment are the classification of Reusable Insulin Delivery Device, applicability of concessional rate of duty, and the entitlement to Cenvat credit on inputs and input services.

Classification of Reusable Insulin Delivery Device:
The appellant, a manufacturer of Reusable Insulin Delivery Device, classified their product under Central Excise Tariff Heading 9018 3100, availing the benefit of a concessional rate of duty under Notification No. 12/2012-CE. The Department contended that the product falls under Serial No. 309 of the notification, attracting a nil rate of duty for 'parts and accessories' of goods under specific headings. The appellant argued that their product, 'Syringes without needles', falls under Chapter sub-heading 9018 3100 and is entitled to the concessional rate of duty at 6% under Serial No. 310 of the notification.

Applicability of Concessional Rate of Duty:
The appellant claimed that their Reusable Insulin Delivery Device, classified as 'Syringes without needles', is a complete product used for administering insulin, not a part or accessory. They contended that the product qualifies for the concessional rate of duty under Serial No. 310 of the notification. The Tribunal observed that the product indeed falls under Chapter sub-heading 9018 3100 and is entitled to the concessional rate of duty, rejecting the Department's contention.

Entitlement to Cenvat Credit:
The key question was whether the appellant could avail Cenvat credit on inputs and input services used in manufacturing the Reusable Insulin Delivery Device, considering the dispute over the classification and duty rate. The Tribunal determined that the appellant correctly paid excise duty at the concessional rate of 6% and was entitled to Cenvat credit, overturning the Department's demands for reversal of credits.

The Tribunal concluded that the Reusable Insulin Delivery Device, classified as 'Syringes without needles', falls under Chapter sub-heading 9018 3100 and is entitled to the concessional rate of duty under Serial No. 310 of Notification No. 12/2012-CE. Therefore, the impugned orders-in-appeal were set aside, and the appeals were allowed.

---